Cleveland Clinic and G42: AI to Advance Healthcare Innovation

Cleveland Clinic and G42, a global powerhouse in artificial intelligence (AI), are joining forces to drive groundbreaking AI applications in healthcare. Their collaboration aims to harness cutting-edge technology to transform patient care and medical research.

Establishing a Joint Task Force for AI Development

As part of this initiative, both organizations will establish a dedicated task force to identify, assess, and fast-track high-potential AI projects. This collaboration will focus on accelerating AI adoption in healthcare, enhancing efficiency, and unlocking new opportunities for medical innovation.

G42: A Leading Force in AI and Healthcare Innovation

Based in Abu Dhabi, UAE, G42 is a technology conglomerate renowned for its expertise in artificial intelligence, digital infrastructure, and big data solutions. Its healthcare subsidiary, M42, operates 480 clinics across 26 countries and leads pioneering health initiatives, including the Emirati Genome Program—the world’s most extensive genomics project—and Malaffi, Abu Dhabi’s groundbreaking Health Information Exchange.

Cleveland Clinic’s Global Healthcare Impact

Cleveland Clinic is an internationally recognized healthcare system with 23 hospitals and 280 outpatient centers, spanning the United States, Canada, the UAE, and the UK. In 2024 alone, it recorded 15.7 million outpatient visits, 333,000 hospital admissions, and 320,000 surgical procedures worldwide, solidifying its role as a leader in patient care.

“Cleveland Clinic is committed to finding opportunities that improve patient safety, patient experience, patient outcomes and access,” said Cleveland Clinic CEO and President Tom Mihaljevic, M.D., holder of the Morton L. Mandel CEO Chair. “Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health and educating those who serve.”

AI-Powered Innovation for Global Healthcare Transformation

Through this collaboration, Cleveland Clinic and G42 will develop and deploy AI-driven healthcare solutions designed to revolutionize patient treatment, improve operational efficiencies, and drive medical breakthroughs. While the UAE and its surrounding region stand to benefit, the impact of this partnership is expected to extend globally, shaping the future of AI-integrated healthcare.

“AI’s potential to transform the healthcare industry remains largely untapped,” said Peng Xiao, Group CEO of G42. “From deciphering the source code of life - our genome - to optimizing efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalized and preventative. We look forward to embarking on this journey alongside Cleveland Clinic and other global partners, harnessing AI to unlock new frontiers in medicine, empower clinicians with unprecedented insights, and ultimately, reshape the way humanity experiences health and longevity."

Cleveland Clinic’s Legacy of Medical Breakthroughs

Ranked as the world’s No. 2 hospital for the seventh consecutive year by Newsweek in 2025, Cleveland Clinic has a long history of medical advancements. The institution has pioneered life-changing procedures such as coronary artery bypass surgery, deep brain stimulation for stroke recovery, and the first-ever face transplant in the United States. In 2023, Cleveland Clinic installed IBM Quantum System One, the first quantum computer dedicated exclusively to healthcare research, further reinforcing its commitment to accelerating biomedical discoveries.